The Nuts and Bolts of Getting into the Business of Cannabis
When thinking about the cannabis industry, most people don’t immediately consider the financial side of it.
The reality is that the legal marijuana business—medical and recreational—is a major industry in the United States, estimated at over $7.1 billion in total revenue for 2016. The ArcView Group, an investment firm with roots in the cannabis industry, estimates that gross sales could easily jump to over $10 billion annually within the next year. That is an almost unprecedented level of growth in any industry, to say nothing of the fact that “new industries” are harder to come by for those who want to get in on the ground floor. As a solid and reputable growth area, it’s still in its infancy, but cannabis has the potential to be an industry worth pursuing for budding entrepreneurs.
Investing in Cannabis Is Recession Proof
When times are hard, people still want certain things in life, certain little luxuries or privileges. As a result, the cannabis industry, like the liquor business, is relatively recession proof. And as the use of cannabis has become more socially acceptable, particularly in the area of medical marijuana, where the sanction of the medical profession allays the fears that some might have of the business, the demand has been growing steadily. It’s still an industry in its infancy, relatively speaking, which means that there is also tremendous opportunity for those who want to take risks in a new industry.
Dream Queen (Hybrid)
Durban Poison (Sativa)
Everything You Want to Know about Pot’s Health Effects
NEW YORK (AP) — It can almost certainly ease chronic pain and might help some people sleep, but it’s also likely to raise the risk of getting schizophrenia and might trigger heart attacks.
Those are among the conclusions about marijuana reached by a federal advisory panel in a report released Thursday.
The experts also called for a national effort to learn more about marijuana and its chemical cousins, including similarly acting compounds called cannabinoids.
The current lack of scientific information “poses a public health risk,” said the report , released by the National Academies of Sciences, Engineering and Medicine. Patients, health care professionals and policy makers need more evidence to make sound decisions, it said.
Several factors have limited research. While the federal government has approved some medicines containing ingredients found in marijuana, it still classifies marijuana as illegal and imposes restrictions on research. So scientists have to jump through bureaucratic hoops that some find daunting, the report said.
- 193,041 Views Category: Odd
- 152,044 Views Category: Fun
- 141,538 Views Category: Culture
- 103,745 Views Category: Culture
- 102,235 Views Category: Culture
- 101,278 Views Category: Fun
- 81,821 Views Category: Culture
- 79,982 Views Category: Odd
- 71,915 Views Category: Fun
- 65,302 Views Category: Fun